- Home
- AVNW vs ADCT Comparison
AVNW vs ADCT Comparison
Compare AVNW & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNW
- ADCT
- Stock Information
- Founded
- AVNW 2006
- ADCT 2011
- Country
- AVNW United States
- ADCT Switzerland
- Employees
- AVNW N/A
- ADCT N/A
- Industry
- AVNW Radio And Television Broadcasting And Communications Equipment
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- AVNW Technology
- ADCT Health Care
- Exchange
- AVNW Nasdaq
- ADCT Nasdaq
- Market Cap
- AVNW 241.8M
- ADCT 143.1M
- IPO Year
- AVNW 2007
- ADCT 2020
- Fundamental
- Price
- AVNW $19.15
- ADCT $1.72
- Analyst Decision
- AVNW Strong Buy
- ADCT Strong Buy
- Analyst Count
- AVNW 5
- ADCT 5
- Target Price
- AVNW $37.60
- ADCT $8.50
- AVG Volume (30 Days)
- AVNW 168.8K
- ADCT 374.9K
- Earning Date
- AVNW 04-30-2025
- ADCT 05-05-2025
- Dividend Yield
- AVNW N/A
- ADCT N/A
- EPS Growth
- AVNW N/A
- ADCT N/A
- EPS
- AVNW N/A
- ADCT N/A
- Revenue
- AVNW $434,108,000.00
- ADCT $70,717,000.00
- Revenue This Year
- AVNW $8.97
- ADCT $6.81
- Revenue Next Year
- AVNW $7.64
- ADCT $11.24
- P/E Ratio
- AVNW N/A
- ADCT N/A
- Revenue Growth
- AVNW 22.94
- ADCT N/A
- 52 Week Low
- AVNW $12.96
- ADCT $1.39
- 52 Week High
- AVNW $38.85
- ADCT $5.38
- Technical
- Relative Strength Index (RSI)
- AVNW 39.29
- ADCT 51.03
- Support Level
- AVNW $19.77
- ADCT $1.50
- Resistance Level
- AVNW $21.07
- ADCT $1.89
- Average True Range (ATR)
- AVNW 1.07
- ADCT 0.14
- MACD
- AVNW -0.39
- ADCT 0.02
- Stochastic Oscillator
- AVNW 6.53
- ADCT 57.14
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.